| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.78▲ | 1.78▲ | 1.78▲ | 1.79▼ | 1.81▼ |
| MA10 | 1.80▼ | 1.81▼ | 1.82▼ | 1.81▼ | 1.82▼ |
| MA20 | 1.85▼ | 1.86▼ | 1.87▼ | 1.85▼ | 1.93▼ |
| MA50 | 1.94▼ | 1.92▼ | 1.90▼ | 1.84▼ | 2.24▼ |
| MA100 | 1.94▼ | 1.90▼ | 1.94▼ | 1.96▼ | N/A |
| MA200 | 2.00▼ | 2.04▼ | 1.99▼ | 2.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.007▼ | -0.010▼ | -0.011▼ | 0.012▲ |
| RSI | 44.026▼ | 44.459▼ | 45.089▼ | 46.124▼ | 44.469▼ |
| STOCH | 30.164 | 23.160 | 21.024 | 52.898 | 17.047▼ |
| WILL %R | -75.000 | -75.000 | -75.000 | -50.265 | -86.053▼ |
| CCI | -51.076 | -54.599 | -58.047 | -45.177 | -58.319 |
|
Tuesday, October 21, 2025 05:15 AM
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a conference call and webcast on ...
|
|
Tuesday, October 21, 2025 04:42 AM
Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus ...
|
|
Thursday, October 16, 2025 05:11 AM
About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/25 | 1.79 | 1.79 | 1.79 | 1.79 | 30,264 |
| 20/10/25 | 1.75 | 1.75 | 1.75 | 1.75 | 700 |
| 17/10/25 | 1.70 | 1.77 | 1.70 | 1.75 | 18,400 |
| 16/10/25 | 1.87 | 1.87 | 1.76 | 1.82 | 7,700 |
| 15/10/25 | 1.7747 | 1.87 | 1.7209 | 1.86 | 10,967 |
| 14/10/25 | 1.70 | 1.814 | 1.602 | 1.80 | 13,000 |
| 13/10/25 | 1.81 | 1.818 | 1.72 | 1.73 | 5,358 |
| 10/10/25 | 1.88 | 1.91 | 1.77 | 1.78 | 31,000 |
| 09/10/25 | 1.91 | 1.95 | 1.90 | 1.91 | 10,349 |
| 08/10/25 | 1.89 | 1.94 | 1.843 | 1.94 | 165,800 |
|
|
||||
|
|
||||
|
|